TY - BOOK AU - Aktolun,C. AU - Goldsmith,Stanley J. TI - Nuclear oncology SN - 9781451186857 PY - 2015///] CY - Philadelphia PB - Wolters Kluwer KW - Cancer KW - Radionuclide imaging KW - Radiotherapy KW - Radioisotope scanning KW - Radionuclide Imaging KW - Neoplasms KW - diagnostic imaging KW - radiotherapy KW - methods KW - Radiation Oncology N1 - Includes bibliographical references and index; Brain tumors; Zuzan Cayci --; Head and neck carcinomas; Muhammad Ali Chaudhry, Lujaien Al-Rubaiey Kadhim, and Richard L. Wahl --; Thyroid carcinoma; Cumali Aktolun, Umut Elboga and Muammer Urhan --; Parathyroid tumors; Christopher J. Palestro and Kenneth J. Nichols --; Esophageal carcinoma; Mark Dunphy and Heiko Schoder --; Gastric carcinoma-I; Ken Herrmann [and others] --; Gastric carcinoma-II; Kemal Metin Kir and Elgin Ozkan --; Pancreatic carcinoma; Christina Blumel and Andreas K. Buck --; Colorectal carcinoma; Gregory C. Ravizzini, Revathy B. Lyer, and Homer A. Macapinlac --; Liver tumors; Scarlett Lewitschnig [and others] --; Breast carcinoma; Cumali Aktolun, Muammer Urhan, and Umut Elboga --; Pulmonary carcinoma; Pietro Muto [and others] --; Renal carcinoma; Antonija Balenovic, Jasna Mihailovic, and Katherine Zukotynski --; Prostate carcinoma; Marina Hodolic and Stanley J. Goldsmith --; Uterine and cervical carcinoma; Berna Degirmenci Polack --; Ovarian carcinoma; Marie Lacombe [and others] --; Testicular germ cell tumors; Christoph Oing, Carsten Bokemeyer, and Karin Oechsle --; Tumors of the adrenal glands; Shinji Yamamoto, Per Hellman and Anders Sundin --; Neuroendocrine tumors; Lisa Bodei [and others] --; Lymphoma and leukemia; Jasna Mihailovic and Stanley J. Goldsmith --; Melanoma; Alice Lorenzoni [and others] --; Neuroblastoma; Ettore Seregni [and others] --; Bone tumors; Johannes Czernin and Ken Herrmann --; Pediatric tumors; Reza Vali and Martin Charron --; Cancer of unknown primary; Zohar Keidar, Gad Abikhzer, and Ron Epelbaum --; Assessment of lymph nodes in oncology; Ansje S. Fortuin [and others] --; Sentinel lymph node detection and imaging in oncology; Gang Cheng, Drew A. Torigian and Abass Alavi --; PET/CT hybrid imaging in radiotherapy planning; Egesta Lopci [and others] --; Bone mineral densitometry in oncology; William D. Leslie --; Non-FDG PET/CT imaging in oncology; Cristina Nanni [and others] --; Assessment of response to antitumor treatment; Masahiro Yanagawa [and others] --; Radionuclide imaging for the assessment of toxicity due to chemotherapy; Marcel P.M. Stokkel and Linda de Wit-van der Veen --; Radionuclide imaging of multidrug resistance; Sabina Dizdarevic and A. Michael Peters. --; Radionuclide imaging of tumor hypoxia and its clinical implications; Gang Niu and Xiaoyuan Chen --; Radionuclide imaging of tumor cell apoptosis; Paola A. Erbe [and others] --; Radionuclide imaging of tumor angiogenesis; Zhao-Hui Jin, Takako Furukawa, and Tsuneo Saga --; Radionuclide imaging of tumor cell proliferation; Sridhar Nimmagadda and Anthony F. Shields --; Radionuclide imaging of human epidermal receptors; Sibaprasad Bhattacharyya [and others] --; Radionuclide imaging of integrins; Masashi Ueda, Takashi Temma, and Hideo Saji --; Radionuclide imaging of annexins; Christel Vangestel [and others] --; Radiochemistry in nuclear oncology; Roland Haubner and Olaf Prante --; Advances in nuclear and optical imaging of tumors : multi-modality, small-animal, and intraoperative technologies; Pat Zanzonico N2 - Nuclear Oncology a contemporary narrative of the role of nuclear medicine in oncology with an emphasis on SPECT/CT and PET/CT with additional comments when appropriate on the potential application of PET/MR and to a lesser degree, targeted radionuclide therapy. This book focuses on the use of radionuclides in the diagnosis and treatment of malignant diseases. It describes relevant approved and investigational clinical applications, instrumentation and technology, chemistry and practical clinical issues in nuclear oncology. The basic science and current research topics of nuclear oncology are addressed in separate chapters. Nuclear medicine has become an essential component to all phases of the management of the patient with a malignant tumor and in some cases, even benign neoplasms. The standard of practice for many tumors requires PET/CT imaging at various stages of diagnosis and management. In addition to clinical applications, ongoing investigational efforts, which more and more involve multi-institutional protocols, are also presented.Features:;*;Focuses on the use of radionuclides in the diagnosis and treatment of malignant diseases;*;Emphasizes SPECT/CT and PET/CT with additional emphasis on the potential application of PET/MR;*;Describes relevant approved and investigational clinical applications, instrumentation and technology, chemistry and practical clinical issues in nuclear oncology UR - https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1484404 ER -